We are live on ! Find out more
MU

Mirova US Portfolio holdings

AUM $8.81B
1-Year Est. Return 21.38%
This Fund
S&P 500
This Quarter Est. Return
+11.23%
1 Year Est. Return
+21.38%
3 Year Est. Return
+80.7%
5 Year Est. Return
+106.85%
10 Year Est. Return
AUM
$4.98B
AUM Growth
+$697M
Cap. Flow
+$242M
Cap. Flow %
4.87%
Top 10 Hldgs %
59.82%
Holding
31
New
2
Increased
23
Reduced
6
Closed

Top Buys

Rank Stock Value
1
SIVB
SVB Financial Group
SIVB
+$158M
2
NVDA icon
NVIDIA
NVDA
+$94M
3
AGCO icon
AGCO
AGCO
+$76.3M
4
EBAY icon
eBay
EBAY
+$75.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$8.69M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$70.1M
2
MELI icon
Mercado Libre
MELI
+$64.9M
3
DE icon
Deere & Co
DE
+$34.7M
4
MA icon
Mastercard
MA
+$23.3M
5
V icon
Visa
V
+$17.9M

Sector Composition

Rank Sector Weight
1 Technology 27.02%
2 Healthcare 20.33%
3 Financials 17.25%
4 Consumer Discretionary 11.34%
5 Industrials 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBNY
26
DELISTED
Signature Bank
SBNY
$59.3M 1.19%
514,969
-128,154
-20% -$17.6M
DE icon
27
Deere & Co
DE
$161B
$55.6M 1.12%
129,665
-85,369
-40% -$34.7M
BFAM icon
28
Bright Horizons
BFAM
$4.03B
$44.3M 0.89%
701,762
+16,956
+2% +$1.11M
FSLR icon
29
First Solar
FSLR
$22.8B
$6.57M 0.13%
43,865
+215
+0.5% +$31.9K
WM icon
30
Waste Management
WM
$96.1B
$534K 0.01%
3,401
+187
+6% +$30.1K
CL icon
31
Colgate-Palmolive
CL
$74.4B
$201K ﹤0.01%
+2,545
New +$191K

Similar funds

Mirova US's Q4 2022 Portfolio in Review

As of Q4 2022, Mirova US held 31 positions worth $4.98B, up 16% from $4.28B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Mirova US deployed $242M of net new capital in Q4 2022, opening 2 new positions and adding to 23 existing holdings. Its largest new stake was AGCO: 618,588 shares worth $85.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $70.1M trimmed.

  • Mirova US's largest Q4 2022 buy was AGCO: 618,588 shares worth $85.8M.
  • Mirova US added most to SVB Financial Group in Q4 2022, an estimated $158M increase.
  • Mirova US's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $70.1M.
  • Mirova US's ten largest holdings make up 60% of its $4.98B portfolio in Q4 2022.
  • Mirova US opened 2 new positions and closed 0 in Q4 2022.
  • Mirova US's portfolio value rose 16% quarter-over-quarter to $4.98B.

Based on Mirova US's 13F filing for Q4 2022, filed 9 Feb 2023.